Oseltamivir tablets/capsules 75 mg, Paracetamol tablets/capsules 500 mg, Dexamethasone, solution for injection 4 mg/ml, Chlorhexidine, solution for external use 0.05% per 100 ml, Bisoprolol tablets 5 mg, Lidocaine, solution for injection, 20 mg/ml, 2 ml each, Diclofenac solution for injection25 mg/ml, Amiodarone, solution for injection, 50 mg/ml, 3 ml each, Drotaverin solution for injection 20 mg/ml, 2 ml each in an ampoule, Prednisone, solution for injection, 30 mg/ml, 1 ml each, Validol tablet
By: Kirilyuk Evgenia Vasylivna📍 UkraineClosed
Key Information
| Reference | GB-UA-2026-09-29-006001-a |
|---|
| Deadline | Oct 2, 2026 12:00 AM |
|---|
| Estimated Value | UAH 1,135,500.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 23400, Ukraine, Vinnytsia region, Murovani Kurylivtsi, Zhovtneva 87 |
|---|
| Published | Sep 29, 2026 |
|---|
Description
Oseltamivir tablets/capsules 75 mg, Paracetamol tablets/capsules 500 mg, Dexamethasone, solution for injection 4 mg/ml, Chlorhexidine, solution for external use 0.05% per 100 ml, Bisoprolol tablets 5 ...
Full details are available after unlocking this tender.